Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
... ended June 30, 2009, a significant improvement over
the same period in 2008. Isis also reported a pro ... debt at a discount, which Isis is amortizing over
the expected life of the debt as additional ... net income per share for the first half of 2009 over
the same period in 2008 was primarily due to the ...
Study Shows Brain Fitness can Save Medicare Billions
... enrollees grows from 44 million to 61 million over
the next ten years, this represents more than ... was based on a total of ten hours of training over
one initial six-week period. Participants have ... brain fitness programs. The company works with over
50 scientists from prestigious universities to ...
Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment
... refinements for coiling are underway all over
But while the efficacy of minimally invasive coiling has been proven many times over
in the case of intracranial aneurysms (a bulge in ... aneurysms, carotid stenosis and spine fractures. over
the past two decades, our physicians have made ...
Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
... we have had great success with the product over
the past few years as it's easy to administer and ... that are completely absorbed by the body over
time and require repeat injections to maintain ... of Artefill has been extensively studied over
the past eight years. Since Artefill was approved ...
Relievant Medsystems Announces Completion of $20 Million Financing
... partnering with more than 300 emerging companies over
forty years. With offices in Menlo Park, Boston and Boulder, the firm manages over
$3 billion in capital and invests in early stage ... 63 mergers and acquisitions, and brought over
50 companies public. www.canaan.com
New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
... or HP-hMG) offered considerable cost-savings over
follicle stimulating hormone ... budget, as it
offers considerable cost savings over
rFSH, not only in terms of costs per
treatment ... in producing live-births over
rFSH in women undergoing
conventional IVF and, ...
AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
... significant reductions in pain intensity over
the 12-hour study period.
This multicenter, ... measure of the difference in pain intensity over
the 12-hour study compared to baseline). Both ... significant reductions in pain intensity over
the study period (p<0.001 for each) based on ...
Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
... and sustained decrease in seizure frequency over
Results from the ... after a 2-week titration period, were assessed over
a 12 week
maintenance period, with continued follow-up over
a one year open-label
GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
... at the meeting, highlighting significant progress over
the past year. A few of the key advances ... to significantly decrease the prevalence of AIDS over
About GeoVax Labs, Inc.
GeoVax ... to use than GeoVax's products, and other factors over
which GeoVax has no control. GeoVax assumes no ...
CoAxia, Inc. Announces $21.5M Series D Financing
... ischemic stroke. The company has now enrolled over
75% of its goal of approximately 500 patients, ... sectors. Since 1972, the firm has financed over
450 companies, many of which have gone public or have been acquired, and currently manages over
euro 1 billion in assets. Sofinnova's experienced ...
Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs
... These three programs represent an investment of over
$16 Million so far to build a SMA drug pipeline. ... data package. Families of SMA will be working over
the next several months with toxicology and ... the 25th Anniversary SMA Conference. A record of over
900 families and researchers were present at the ...
HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
... 2010. The first trial showed promising results over
a four-fold range of cell concentrations ... and actual direct treatment costs reported to be over
$9,000 per patient, the current annual cost of ... plus standard care, in healing venous leg ulcers over
a 12-week treatment period. All trial patients ...
Neurocrine Biosciences Presents Elagolix Data
... a Phase I study in which elagolix was evaluated over
six weeks (42 days) in 60 healthy premenopausal ... fashion to maintenance of low estradiol levels over
the six week period without inducing severe hot ... 104 (used as an active control) administered over
six months followed by six months of additional ...
VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
... The new LifeShirt has significant advantages over
currently available monitoring technologies, ... resulting from RPM will reach $200 billion over
the next 25 years in the United States alone(1). ... It's exciting for us to be able to draw upon over
10 years of experience acquiring quality data in ...
Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight
... managing type 2 diabetes, a disease that affects over
250 million people worldwide.
In the ... of how well blood sugar is being controlled over
time - with albiglutide 30 mg weekly, 50 mg ... "Despite a range of available diabetes therapies, over
half of patients with type 2 diabetes are unable ...
Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
... 32.1% of patients on placebo (p<0.0001), and over
one-third (36.2%) of lorcaserin patients lost at ... data demonstrate that treatment with lorcaserin over
one year was associated with highly significant ... of valvulopathy for lorcaserin patients crossing over
to placebo were 3.6% and 1.9%, respectively.
AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
... prospective, multicenter, phase 3 study conducted over
a two-year period showed no difference in mean ... were based on pulmonary function tests (PFTs) over
a 2-year period in subjects with type 1 and 2 ... group. Based on the predefined endpoint, over
2 years, there was no difference in mean change ...
Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
... literature suggesting biomarker stability over
similar time periods. Further studies are ... the impact of therapy on biomarker stability over
longer periods of time.
The clinical utility ... patients is expected to increase significantly over
the next several years, driven by broad-based ...
PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
... Activity Index (CDAI) score of at least 70 points over
the course of 12 weeks; the more stringent ... maintaining response/remission in Crohn's disease over
a combined total of 12 months. The Induction ... oral dosing. Traficet-EN may offer advantages over
existing therapeutic approaches for Crohn's ...
Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
... both in terms of lowering dexamethasone use over
the longer-term and the impact seen in metastatic ... dexamethasone dosing much better than anticipated over
this time frame.
However, at weeks two, ... (p=0.001) improvement compared to placebo over
the twelve weeks of study duration in reducing ...
PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
... in managing oncology-based clinical trials over
the last five years, which have involved over
175,000 patients in hundreds of programs across ... throughout 52 countries around the world, and has over
9,400 employees. For more information about ...
Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimer's Disease
... the development efforts to be conducted by BRNI over
an initial three year period. Inverness has also ... diseases such as Alzheimer's."
5 million Americans, Alzheimer's disease (AD) has ... was $21 billion. Dementia currently afflicts over
29 million people worldwide, and the annual ...
Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
... 4 co-leaders and 27 principal researchers from over
20 leading institutions, with more than 300 ... cancer. These grants will provide up to $750,000 over
a three-year term, and will be awarded to ... If the Dream Teams produce tangible results over
these next three years, the Stand Up To Cancer ...
New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
... HCl IR 10-mg, or placebo every four to six hours over
a 72-hour period following surgery. The primary ... was the sum of pain intensity difference (SPID) over
the first 48 hours of treatment. The secondary endpoints included SPID over
the first 12, 24, and 72 hours of treatment, ...
Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data
... May 23 /PRNewswire/ -- Amid all the speculation over
what course the Swine Flu epidemic will take, ... showed an increase of 46% in the Replikin Count* over
the past five months. This points to a marked ... and pandemics of the common influenza strains over
the past century.
About Replikins Ltd .
Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
... to enroll a total of 2,000 patients age 55 and over
from 16 countries.
In 2008, Lilly began ... 4,600 patients with Alzheimer's disease in over
30 countries around the world.
EXPEDITION ... Estimates show that 6-8 percent of people over
age 65 are affected by Alzheimer's disease(iii), ...
Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
... 80 mg and 120 mg once daily compared to placebo, over
six weeks in patients with acute schizophrenia. ... was change from baseline in the PANSS total score over
the six-week study duration for each lurasidone ... endpoint was the change from baseline in CGI-S over
the six-week study period. Efficacy data were ...
Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
... lost many relatives and friends to HIV/AIDS over
the years, I found Dr. Robinson's quest for a ... people from all classes in America and all over
the world. Chuck is a true advocate of what we ... to use than GeoVax's products, and other factors over
which GeoVax has no control. GeoVax assumes no ...
Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
... change from baseline, assessing treatment effect over
the full duration of the study showed that ... that pirfenidone has on the progression of IPF over
at least one year."
About CAPACITY and ... cough and is a progressive disease, meaning that over
time, lung scarring and symptoms increase in ...
Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data
... Technology closer to market as an option for the over
14 million patients in the United States and ... procedure keeps the vessels open wider over
time compared to standard angioplasty and ... services. MEDRAD's total 2008 revenues were over
$600 million. The company's world headquarters is ...
New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy
... analysis shows a sustainable mortality benefit over
At eight ... ICD. This represents a significant improvement over
the two-year MADIT II data, which showed one life ... life-saving benefits of these devices continue over
time," said Arthur J. Moss, M.D., Professor of ...
Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
... which require careful dose escalation over
months and several years of maintenance ... standardized doses of ToleroMune treatment over
a number of weeks.
During the trial investigators ... are very
common in the US, where they affect over
a quarter of the population, and are
a growing ...
CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License
... (ALI). IC14 has a demonstrated safety profile in over
150 patient exposures, and initial data from a ... and appreciate their particular insights gained over
their years of experience in the earlier ... cases per annum in the US and is responsible for over
75,000 deaths - more than breast cancer and HIV ...
Methadone Frequently Causes Menopausal Symptoms in Young Women
... daily. Florida Detox has successfully detoxed over
100 methadone patients who were using over
1000 milligrams of methadone daily
Florida ... Cocaine dependency. Florida Detox has treated over
5,000 patients for chemical dependency.
Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity
... that achieved with placebo among 756 patients over
28 weeks. Patients taking full-dose and mid-dose ... "The weight loss seen in patients taking Qnexa, over
just 28 weeks, is encouraging for those of us in ... weight loss of five percent of weight, maintained over
time, can bring significant health benefits by ...
BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
... products is expected to increase substantially over
the next several years to $688.9 M in 2009 and ... types are expected to be of increasing interest over
the next couple of years. By 2011, osteogenic ... excitement, especially in the academic community, over
the recent Executive Order signed by President ...
Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
For more than 30 years, LEITR has provided over
30,000 corneas for transplant and 50,000 eyes for ... the highest quality human tissue available. over
the years, LEITR recognized that time between ... upwards of 3 million Americans, contributes to over
120,000 new cases of blindness each year and is ...
ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert;
... providing a rich resource of data to mine over
Association for Research in Vision ... the study significantly improved by more than 25% over
the four weeks of the study; this was over
and above any improvement patients may have ...
Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
... statistical applications, was attended by over
500 professionals from the biopharmaceutical ... which has supported the implementation of over
100 adaptive trials, provides eClinical ... throughout 52 countries around the world, and has over
9,400 employees. For more information about ...
Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
... treatment groups than in the placebo group. over
the two-year period of the study, 80% of the ... (another secondary endpoint) relative to placebo over
the two-year period of the study (low-dose ... shown and were consistent with clinical outcomes. over
the two year period of the study, both dose ...